https://www.biopharm.org.tw
+886-2-2655-8135
services@biopharm.org.tw
Company Profile
Golden Biotechnology Corporation (GBC,GoldenBiotech, TPEx:4132), founded in 2002, is a Taiwanese based leading and clinical stage pharmaceutical company which dedicates to discovering new compounds and developing innovative therapeutics against serious and rare diseases in improving and promoting a lasting quality of life, health and longevity. GBC also develops evidence-based health supplement products.
GoldenBiotech has established not only PIC/S GMP certificated facilities, but also chemical synthesis plant. Now GBC is conducting and well prepared for clinical development as well as future global market demands with all possible collaborations.
GBC’s small molecular NCE and chemical synthesized drug, Antroquinonol(HOCENA) discovered in 2006 and its compound structure, preparation methods and applicable indications have been protected with patents worldwide. as of today, there are a total of more than 150 patents in over 40 countries/regions.
The current pipeline of Antroquinonol includes Phase2,clinical trials in COVID-19, Non-small cell lung cancer (NSCLC), Pancreatic cancer, Acute myeloid leukemia (AML), Hepatocellular carcinomas, Alzheimer's disease, Hypercholesterolemia and hyperlidemia, Atopic dermatitis, and hepatitis.
Product / Service
- Seeking for Licensing-out Partner
GBC’s small molecular NCE and chemical synthesized drug, Antroquinonol and GBC is seeking for licensing-out global or regional partners in EU, US and Asia. And the small molecular drug is approved as safety and efficacy in late-stage clinical trial on Cancer treatment and infectious disease treatment.
Late-stage Clinical Trial (Phase II complete)- Acute myeloid leukemia (AML)
- Non-small-cell lung carcinoma (NSCLC)
- Hyperlipidemia
- Pancreatic Cancer
- COVID-19
- Atopic dermatitis
- Alzheimer’s disease
- Non-alcoholic fatty liver disease (NASH)
- Seeking for Global Investor or joint venture
GBC is preparing for IPO with stable cash-flow and financial condition.
Business Interests
Distribution, Licensing, Investment
Contact Info
Charles Yeh
Associate Vice President
charlesyeh@goldenbiotech.com
886-2-2808-6006
Official Website
Corporate Video
The Mode of Actions for Antroquinonol- GoldenBiotech
DM.pdf